Prevalence and patterns of mutations in RAS/RAF/MEK/ERK/MAPK signaling pathway in colorectal cancer in North Africa

被引：0
|
作者：
Meryem Jafari
Abdelilah Laraqui
Walid Baba
Soukaina Benmokhtar
Sara El Zaitouni
Abdelmounaim Ait Ali
Ahmed Bounaim
Mountassir Moujahid
Rachid Tanz
Tarik Mahfoud
Yassir Sbitti
Hicham El Annaz
Rachid Abi
Mohamed Rida Tagajdid
Safae El Kochri
Idriss Amine Lahlou
Houda El Hsaini
Lamiae Belayachi
Abdelaziz Benjouad
Mohammed Ichou
Amina En-Nya
Khalid Ennibi
机构：
[1] Mohammed V Military Teaching Hospital,Sequencing Unit, Laboratory of Virology, Center of Virology, Infectious and Tropical Diseases, Faculty of Medicine and Pharmacy
[2] Mohammed V University in Rabat,Laboratory of Biology of Human Pathologies, Department of Biology, Faculty of Sciences
[3] Genomic Center of Human Pathologies,Department of Digestive Surgery, Faculty of Medicine and Pharmacy
[4] Mohammed V University in Rabat,Department of Medical Oncology, Faculty of Medicine and Pharmacy
[5] Mohammed V Military Hospital,International Faculty of Dental Medicine
[6] Mohammed V University in Rabat,Center of Virology, Infectious and Tropical Diseases, Faculty of Medicine and Pharmacy
[7] Mohammed V Military Teaching Hospital,undefined
[8] Mohammed V University in Rabat,undefined
[9] College of Health Sciences,undefined
[10] International University in Rabat,undefined
[11] Mohammed V Military Teaching Hospital,undefined
[12] Mohammed V University in Rabat,undefined
来源：
BMC Cancer | / 22卷
关键词：
And ; mutations; Colorectal cancer; Lifestyle factors; North Africa;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Prevalence and patterns of mutations in RAS/RAF/MEK/ERK/MAPK signaling pathway in colorectal cancer in North Africa
    Jafari, Meryem
    Laraqui, Abdelilah
    Baba, Walid
    Benmokhtar, Soukaina
    El Zaitouni, Sara
    Ali, Abdelmounaim Ait
    Bounaim, Ahmed
    Moujahid, Mountassir
    Tanz, Rachid
    Mahfoud, Tarik
    Sbitti, Yassir
    El Annaz, Hicham
    Abi, Rachid
    Tagajdid, Mohamed Rida
    El Kochri, Safae
    Lahlou, Idriss Amine
    El Hsaini, Houda
    Belayachi, Lamiae
    Benjouad, Abdelaziz
    Ichou, Mohammed
    En-Nya, Amina
    Ennibi, Khalid
    [J]. BMC CANCER, 2022, 22 (01)
  • [2] Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation
    J Xu
    N Pfarr
    V Endris
    E K Mai
    N H Md Hanafiah
    N Lehners
    R Penzel
    W Weichert
    A D Ho
    P Schirmacher
    H Goldschmidt
    M Andrulis
    M S Raab
    [J]. Oncogenesis, 2017, 6 : e337 - e337
  • [3] Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation
    Xu, J.
    Pfarr, N.
    Endris, V.
    Mai, E. K.
    Hanafiah, N. H. Md
    Lehners, N.
    Penzel, R.
    Weichert, W.
    Ho, A. D.
    Schirmacher, P.
    Goldschmidt, H.
    Andrulis, M.
    Raab, M. S.
    [J]. ONCOGENESIS, 2017, 6 : e337 - e337
  • [4] The Ras-Raf-MEK-ERK pathway in the treatment of cancer
    Hilger, RA
    Scheulen, ME
    Strumberg, D
    [J]. ONKOLOGIE, 2002, 25 (06): : 511 - 518
  • [5] The potential of RAS/RAF/MEK/ERK (MAPK) signaling pathway inhibitors in ovarian cancer: A systematic review and meta-analysis
    Hendrikse, C. S. E.
    Theelen, P. M. M.
    van der Ploeg, P.
    Westgeest, H. M.
    Boere, I. A.
    Thijs, A. M. J.
    Ottevanger, P. B.
    van de Stolpe, A.
    Lambrechts, S.
    Bekkers, R. L. M.
    Piek, J. M. J.
    [J]. GYNECOLOGIC ONCOLOGY, 2023, 171 : 83 - 94
  • [6] Polymorphisms in RAS/RAF/MEK/ERK Pathway Are Associated with Gastric Cancer
    Gonzalez-Hormazabal, Patricio
    Musleh, Maher
    Bustamante, Marco
    Stambuk, Juan
    Pisano, Raul
    Valladares, Hector
    Lanzarini, Enrique
    Chiong, Hector
    Rojas, Jorge
    Suazo, Jose
    Gonzalo Castro, V
    Jara, Lilian
    Berger, Zoltan
    [J]. GENES, 2019, 10 (01):
  • [7] Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
    Degirmenci, Ufuk
    Wang, Mei
    Hu, Jiancheng
    [J]. CELLS, 2020, 9 (01)
  • [8] Mutational status in Ras/Raf/MAPK signaling pathway in Moroccan colorectal cancer patients
    Sqalli Houssaini, M.
    Damou, M.
    Guessous, F.
    Ismaili, N.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S206 - S206
  • [9] Detection of activating mutations in RAS/RAF/MEK/ERK and JAK/STAT signaling pathways
    Zarubina, K., I
    Parovichnikova, E. N.
    Surin, V. L.
    Pshenichnikova, O. S.
    Gavrilina, O. A.
    Isinova, G. A.
    Troitskaia, V. V.
    Sokolov, A. N.
    Gal'tseva, I., V
    Kapranov, N. M.
    Davydova, Iu O.
    Obukhova, T. N.
    Sudarikov, A. B.
    Savchenko, V. G.
    [J]. TERAPEVTICHESKII ARKHIV, 2020, 92 (07): : 31 - 42
  • [10] Future targeting of the RAS/RAF/MEK/ERK signaling pathway in oncology: the example of melanoma
    Favre, Gilles
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2014, 198 (02): : 321 - 336
12345